
Mandate Will Ensure Researchers, Companies Report Clinical Trial Data, Says Collins
At the Cancer Moonshot Summit, Vice President Joe Biden cautioned research scientists to expect funding cuts if they failed to report, in a timely manner, the findings of clinical trials.
At the Cancer Moonshot Summit, Vice President Joe Biden cautioned research scientists to expect funding cuts if they failed to report, in a timely manner, the findings of clinical trials.
Once this proposal becomes a rule, NIH will have the authority to crackdown on institutions that fail to update trial results, Francis Collins, MD, director of NIH told reporters after the Summit. “That final rule is close to appearing, and we can basically say to Harvard, ‘Sorry, we’re not giving you any dollars until this principal investigator who ran a clinical trial deposits the data,’”
An investigation by STAT,
Accountability is key for ensuring appropriate disbursement of trial results, according to Ben Goldacre, MD, a fellow at the University of Oxford and a cofounder of
During his speech, the Vice President stressed on identifying ways to get rid of these practices. “The impediment isn’t the lack of gray matter genius and ingenuity… It’s all this stuff that gets in the way,” Biden said. “We have to figure out how to get out of the way, and you guys have to figure out how to get in each other’s way more.”
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.